Results 141 to 150 of about 10,308 (152)

Association of Oral Mucosa Hyperpigmentation With Imatinib Mesylate Use: A Cross-Sectional Study and a Systematic Literature Review

Clinical Oral Investigations, 2019
Tarcília Aparecida da Silva, Felipe Fonseca, Sicilia Rezende Oliveira   +2 more
exaly  

Imatinib Mesylate (Gleevec®) in Advanced Breast Cancer-Expressing C-Kit or PDGFR-β: Clinical Activity and Biological Correlations

Annals of Oncology, 2008
Massimo Cristofanilli, J M Reuben, G N Hortobagyi   +2 more
exaly  

Imatinib Mesylate in the Treatment of Systemic Mastocytosis

Cancer, 2006
Arjan A van de Loosdrecht, Arnold P Oranje, Paul L A van Daele   +2 more
exaly  

Imatinib Mesylate — Uncovering a Fast Track to Adaptive Immunity

New England Journal of Medicine, 2006
Mark J. Smyth
exaly  

Imatinib Mesylate — A New Oral Targeted Therapy

New England Journal of Medicine, 2002
exaly  

Solubility Measurement of a Chemotherapeutic Agent (Imatinib Mesylate) in Supercritical Carbon Dioxide: Assessment of New Empirical Model

Journal of Supercritical Fluids, 2019
Gholamhossein Sodeifian, Seyed Ali Sajadian, Fariba Razmimanesh   +2 more
exaly  

Analysis of Total Phosphotyrosine Levels in CD34+ Cells From CML Patients to Predict the Response to Imatinib Mesylate Treatment

Blood, 2005
Jane F Apperley, Richard Szydlo, Beate Schultheis   +2 more
exaly  

Another Look at Imatinib Mesylate

New England Journal of Medicine, 2007
Schellings, Mark W., Löwenberg, Bob, Pinto, Yigal M.   +2 more
openaire   +3 more sources

Imatinib Mesylate

2018
openaire   +1 more source

Imatinib Mesylate

2008
openaire   +1 more source